{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:41:33Z","timestamp":1791726093207,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Research Project of Henan Province","award":["252102311286"],"award-info":[{"award-number":["252102311286"]}]},{"name":"Henan Provincial Charity Federation Hepatobiliary Funding","award":["GDXZ2023015"],"award-info":[{"award-number":["GDXZ2023015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44332-8","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:55:01Z","timestamp":1773683701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell and bulk transcriptomic analyses uncover immune subtypes associated with programmed cell death features in intrahepatic cholangiocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Tiancai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huapeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"44332_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","volume":"34","author":"R Tao","year":"2016","unstructured":"Tao, R. et al. Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: A retrospective dose response analysis. J. Clin. Oncol. 34, 219\u2013226 (2016).","journal-title":"J. Clin. Oncol."},{"key":"44332_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3350\/cmh.2021.0287","volume":"28","author":"M Komuta","year":"2022","unstructured":"Komuta, M. Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance. Clin. Mol. Hepatol. 28, 396\u2013407 (2022).","journal-title":"Clin. Mol. Hepatol."},{"key":"44332_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","volume":"16","author":"PM Rodrigues","year":"2021","unstructured":"Rodrigues, P. M. et al. Pathogenesis of cholangiocarcinoma. Annu. Rev. Pathol. 16, 433\u2013463 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"44332_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle, J. W., Kelley, R. K., Nervi, B., Oh, D. Y. & Zhu, A. X. Biliary tract cancer. Lancet 397, 428\u2013444 (2021).","journal-title":"Lancet"},{"key":"44332_CR5","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","volume":"51","author":"M Qurashi","year":"2025","unstructured":"Qurashi, M., Vithayathil, M. & Khan, S. A. Epidemiology of cholangiocarcinoma. Eur. J. Surg. Oncol. 51, 107064 (2025).","journal-title":"Eur. J. Surg. Oncol."},{"key":"44332_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","volume":"56","author":"SA Khan","year":"2012","unstructured":"Khan, S. A. et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J. Hepatol. 56, 848\u2013854 (2012).","journal-title":"J. Hepatol."},{"key":"44332_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/cancers16030632","volume":"16","author":"V Cortiana","year":"2024","unstructured":"Cortiana, V. et al. Cholangiocarcinoma Insights: Established Foundations and Cutting-Edge Innovations from Dr. James Cleary\u2019s Pioneering Research. Cancers (Basel). 16, 632 (2024).","journal-title":"Cancers (Basel)"},{"key":"44332_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","volume":"73","author":"R Montal","year":"2020","unstructured":"Montal, R. et al. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. J. Hepatol. 73, 315\u2013327 (2020).","journal-title":"J. Hepatol."},{"key":"44332_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","volume":"20","author":"SI Ilyas","year":"2023","unstructured":"Ilyas, S. I. et al. Cholangiocarcinoma - novel biological insights and therapeutic strategies. Nat. Rev. Clin. Oncol. 20, 470\u2013486 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"44332_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten, T. F. et al. Immunology and immunotherapy of cholangiocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 20, 349\u2013365 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"44332_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell. Biol. 25, 379\u2013395 (2024).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"44332_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong, L. et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell. 40, 70\u201387e15 (2022).","journal-title":"Cancer Cell."},{"key":"44332_CR13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12967-023-04468-x","volume":"21","author":"H Qin","year":"2023","unstructured":"Qin, H. et al. Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma. J. Transl Med. 21, 588 (2023).","journal-title":"J. Transl Med."},{"key":"44332_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41698-024-00538-5","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Machine learning reveals diverse cell death patterns in lung adenocarcinoma prognosis and therapy. NPJ Precis Oncol. 8, 49 (2024).","journal-title":"NPJ Precis Oncol."},{"key":"44332_CR15","doi-asserted-by":"publisher","first-page":"37117","DOI":"10.1038\/s41598-025-21123-1","volume":"15","author":"H Yang","year":"2025","unstructured":"Yang, H. et al. Programmed cell death-related genes define distinct molecular subtypes and risk profiles in hepatocellular carcinoma. Sci. Rep. 15, 37117 (2025).","journal-title":"Sci. Rep."},{"key":"44332_CR16","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.3390\/cells11213430","volume":"11","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Identification of SLC3A2 as a potential therapeutic target of osteoarthritis involved in ferroptosis by integrating bioinformatics, clinical factors and experiments. Cells 11, 3430 (2022).","journal-title":"Cells"},{"key":"44332_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12672-025-02310-y","volume":"16","author":"C Li","year":"2025","unstructured":"Li, C. et al. Machine learning-based prognostic modeling integrating PANoptosis in head and neck squamous cell carcinoma. Discov Oncol. 16, 511 (2025).","journal-title":"Discov Oncol."},{"key":"44332_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"44332_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"44332_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"44332_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/cam4.4941","volume":"12","author":"B Bahcivanci","year":"2023","unstructured":"Bahcivanci, B., Shafiha, R., Gkoutos, G. V. & Acharjee, A. Associating transcriptomics data with inflammatory markers to understand tumour microenvironment in hepatocellular carcinoma. Cancer Med. 12, 696\u2013711 (2023).","journal-title":"Cancer Med."},{"key":"44332_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"44332_CR23","doi-asserted-by":"publisher","first-page":"23328","DOI":"10.1038\/s41598-024-74907-2","volume":"14","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Machine learning based intratumor heterogeneity signature for predicting prognosis and immunotherapy benefit in stomach adenocarcinoma. Sci. Rep. 14, 23328 (2024).","journal-title":"Sci. Rep."},{"key":"44332_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nchembio.1986","volume":"12","author":"MG Rees","year":"2016","unstructured":"Rees, M. G. et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat. Chem. Biol. 12, 109\u2013116 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"44332_CR25","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of drug sensitivity in cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013961 (2013).","journal-title":"Nucleic Acids Res."},{"key":"44332_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","volume":"443","author":"GM Morris","year":"2008","unstructured":"Morris, G. M. & Lim-Wilby, M. Molecular docking. Methods Mol. Biol. 443, 365\u2013382 (2008).","journal-title":"Methods Mol. Biol."},{"key":"44332_CR27","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J. Chem. Inf. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"44332_CR28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"44332_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M., Gartner, Z. J. & DoubletFinder doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell. Syst. 8, 329\u2013337e324 (2019).","journal-title":"Cell. Syst."},{"key":"44332_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin, S., Plikus, M. V. & Nie, Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat. Protoc. 20, 180\u2013219 (2025).","journal-title":"Nat. Protoc."},{"key":"44332_CR31","doi-asserted-by":"publisher","first-page":"39751","DOI":"10.1038\/srep39751","volume":"7","author":"P Kumar","year":"2017","unstructured":"Kumar, P. et al. Soluble OX40L and JAG1 Induce selective proliferation of functional regulatory T-cells independent of canonical TCR signaling. Sci. Rep. 7, 39751 (2017).","journal-title":"Sci. Rep."},{"key":"44332_CR32","doi-asserted-by":"publisher","first-page":"114697","DOI":"10.1016\/j.biopha.2023.114697","volume":"162","author":"W Chen","year":"2023","unstructured":"Chen, W. et al. Unraveling the heterogeneity of cholangiocarcinoma and identifying biomarkers and therapeutic strategies with single-cell sequencing technology. Biomed. Pharmacother. 162, 114697 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"44332_CR33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3892\/ol.2024.14739","volume":"28","author":"X Zhao","year":"2024","unstructured":"Zhao, X., Zhang, M., He, J., Li, X. & Zhuang, X. Emerging insights into ferroptosis in cholangiocarcinoma (Review). Oncol. Lett. 28, 606 (2024).","journal-title":"Oncol. Lett."},{"key":"44332_CR34","doi-asserted-by":"publisher","first-page":"e13644","DOI":"10.1111\/cpr.13644","volume":"57","author":"L Yu","year":"2024","unstructured":"Yu, L. et al. Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1\/PD-L1 cancer immunotherapy. Cell. Prolif. 57, e13644 (2024).","journal-title":"Cell. Prolif."},{"key":"44332_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.pharma.2023.02.002","volume":"81","author":"B Corso","year":"2023","unstructured":"Corso, B. et al. Place of therapeutic cannabis in France and safety data: A literature review. Ann. Pharm. Fr. 81, 583\u2013595 (2023).","journal-title":"Ann. Pharm. Fr."},{"key":"44332_CR36","first-page":"e32236","volume":"14","author":"GA Britt","year":"2022","unstructured":"Britt, G. A., Mroch, H., Young, A. M. & Pearce, S. M. Renal schwannoma: A rare case report and literature review. Cureus 14, e32236 (2022).","journal-title":"Cureus"},{"key":"44332_CR37","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.3390\/cancers15143638","volume":"15","author":"M Scimeca","year":"2023","unstructured":"Scimeca, M. et al. Programmed cell death pathways in cholangiocarcinoma: Opportunities for targeted therapy. Cancers (Basel). 15, 3638 (2023).","journal-title":"Cancers (Basel)"},{"key":"44332_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/biom13050820","volume":"13","author":"P Zhou","year":"2023","unstructured":"Zhou, P., Zhang, S., Wang, M. & Zhou, J. The induction mechanism of ferroptosis, necroptosis, and pyroptosis in inflammatory bowel disease, colorectal cancer, and intestinal injury. Biomolecules 13, 820 (2023).","journal-title":"Biomolecules"},{"key":"44332_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12967-025-06421-6","volume":"23","author":"D Chen","year":"2025","unstructured":"Chen, D. et al. The glycolytic characteristics of hepatocellular carcinoma and its interaction with the microenvironment: a comprehensive omics study. J. Transl Med. 23, 424 (2025).","journal-title":"J. Transl Med."},{"key":"44332_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12929-024-01089-4","volume":"31","author":"LC Chang","year":"2024","unstructured":"Chang, L. C., Chiang, S. K., Chen, S. E. & Hung, M. C. Exploring paraptosis as a therapeutic approach in cancer treatment. J. Biomed. Sci. 31, 101 (2024).","journal-title":"J. Biomed. Sci."},{"key":"44332_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21037\/jgo-23-984","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer. J. Gastrointest. Oncol. 15, 63\u201385 (2024).","journal-title":"J. Gastrointest. Oncol."},{"key":"44332_CR42","doi-asserted-by":"publisher","first-page":"e36570","DOI":"10.1016\/j.heliyon.2024.e36570","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. PGRMC2 influences the onset of postmenopausal osteoporosis through disulfidptosis in monocytes: Evidence from experimental validation and Mendelian randomization. Heliyon 10, e36570 (2024).","journal-title":"Heliyon"},{"key":"44332_CR43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41419-022-05044-9","volume":"13","author":"I de Souza","year":"2022","unstructured":"de Souza, I. et al. High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1\/MRP1 upregulation. Cell. Death Dis. 13, 591 (2022).","journal-title":"Cell. Death Dis."},{"key":"44332_CR44","doi-asserted-by":"publisher","first-page":"1370647","DOI":"10.3389\/fimmu.2024.1370647","volume":"15","author":"B Pan","year":"2024","unstructured":"Pan, B. et al. Predicting mitophagy-related genes and unveiling liver endothelial cell heterogeneity in hepatic ischemia-reperfusion injury. Front. Immunol. 15, 1370647 (2024).","journal-title":"Front. Immunol."},{"key":"44332_CR45","doi-asserted-by":"publisher","first-page":"108981","DOI":"10.1016\/j.steroids.2022.108981","volume":"179","author":"S Patel","year":"2022","unstructured":"Patel, S., Bariya, D., Mishra, R. & Mishra, S. Bile acid-based receptors and their applications in recognition. Steroids 179, 108981 (2022).","journal-title":"Steroids"},{"key":"44332_CR46","doi-asserted-by":"publisher","first-page":"1825178","DOI":"10.1080\/2162402X.2020.1825178","volume":"9","author":"S Nair","year":"2020","unstructured":"Nair, S. Differential gene expression of tumor-infiltrating CD4(+) T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis. Oncoimmunology 9, 1825178 (2020).","journal-title":"Oncoimmunology"},{"key":"44332_CR47","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s43018-024-00798-x","volume":"5","author":"M Arias-Badia","year":"2024","unstructured":"Arias-Badia, M., Chang, R. & Fong, L. \u03b3\u03b4 T cells as critical anti-tumor immune effectors. Nat. Cancer. 5, 1145\u20131157 (2024).","journal-title":"Nat. Cancer"},{"key":"44332_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","volume":"22","author":"AM Gocher","year":"2022","unstructured":"Gocher, A. M., Workman, C. J. & Vignali, D. A. A. Interferon-\u03b3: teammate or opponent in the tumour microenvironment? Nat. Rev. Immunol. 22, 158\u2013172 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"44332_CR49","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","volume":"20","author":"A Del Prete","year":"2023","unstructured":"Del Prete, A. et al. Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell. Mol. Immunol. 20, 432\u2013447 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"44332_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","volume":"637","author":"A Elewaut","year":"2025","unstructured":"Elewaut, A. et al. Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature 637, 716\u2013725 (2025).","journal-title":"Nature"},{"key":"44332_CR51","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1124\/mol.65.3.744","volume":"65","author":"S DaCosta Byfield","year":"2004","unstructured":"DaCosta Byfield, S., Major, C., Laping, N. J. & Roberts, A. B. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 65, 744\u2013752 (2004).","journal-title":"Mol. Pharmacol."},{"key":"44332_CR52","doi-asserted-by":"publisher","first-page":"gaae041","DOI":"10.1093\/molehr\/gaae041","volume":"30","author":"A Nakamura","year":"2024","unstructured":"Nakamura, A. et al. mTOR inhibitors as potential therapeutics for endometriosis: A narrative review. Mol. Hum. Reprod. 30, gaae041 (2024).","journal-title":"Mol. Hum. Reprod."},{"key":"44332_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13030-019-0168-x","volume":"13","author":"T Oka","year":"2019","unstructured":"Oka, T., Tanahashi, T., Lkhagvasuren, B. & Yamada, Y. The longitudinal effects of seated isometric yoga on blood biomarkers, autonomic functions, and psychological parameters of patients with chronic fatigue syndrome: a pilot study. Biopsychosoc. Med. 13, 28 (2019).","journal-title":"Biopsychosoc. Med."},{"key":"44332_CR54","doi-asserted-by":"publisher","first-page":"101118","DOI":"10.1016\/j.aohep.2023.101118","volume":"28","author":"S Yang","year":"2023","unstructured":"Yang, S., Peng, L. R., Yu, A. Q. & Li, J. CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-\u03baB pathway. Ann. Hepatol. 28, 101118 (2023).","journal-title":"Ann. Hepatol."},{"key":"44332_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12985-019-1258-x","volume":"16","author":"NA Ilyushina","year":"2019","unstructured":"Ilyushina, N. A. et al. Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies. Virol. J. 16, 149 (2019).","journal-title":"Virol. J."},{"key":"44332_CR56","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12967-025-06243-6","volume":"23","author":"F Zhao","year":"2025","unstructured":"Zhao, F., Chen, M., Wu, T., Ji, M. & Li, F. Integration of single-cell and bulk RNA sequencing to identify a distinct tumor stem cells and construct a novel prognostic signature for evaluating prognosis and immunotherapy in LUAD. J. Transl Med. 23, 222 (2025).","journal-title":"J. Transl Med."},{"key":"44332_CR57","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","volume":"7","author":"D Zeng","year":"2019","unstructured":"Zeng, D. et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunol. Res. 7, 737\u2013750 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"44332_CR58","doi-asserted-by":"publisher","first-page":"665664","DOI":"10.3389\/fmicb.2021.665664","volume":"12","author":"MN Byappanahalli","year":"2021","unstructured":"Byappanahalli, M. N. et al. Influence of filter pore size on composition and relative abundance of bacterial communities and select host-specific MST markers in coastal waters of Southern Lake Michigan. Front. Microbiol. 12, 665664 (2021).","journal-title":"Front. Microbiol."},{"key":"44332_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.pmn.2022.12.004","volume":"24","author":"Y Kondo","year":"2023","unstructured":"Kondo, Y., Higuchi, D., Miki, T., Watanabe, Y. & Takebayashi, T. Influence of pain self-efficacy and gender on disability in postoperative cervical myelopathy. Pain Manag Nurs. 24, 335\u2013341 (2023).","journal-title":"Pain Manag Nurs."},{"key":"44332_CR60","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12967-025-06070-9","volume":"23","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Tumor-associated-fibrosis and active collagen-CD44 axis characterize a poor-prognosis subtype of gastric cancer and contribute to tumor immunosuppression. J. Transl Med. 23, 123 (2025).","journal-title":"J. Transl Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44332-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:03:31Z","timestamp":1777421011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44332-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44332"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44332-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Human cholangiocarcinoma tissue samples were collected at the First Affiliated Hospital of Zhengzhou University (Zhengzhou, China). The study protocol was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval No. 2022-KY-0826-001). Written informed consent was obtained from all participants prior to sample collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"13678"}}